相关实验视频

Updated: May 7, 2025

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

10.8K

大脑洞腔形:从遗传学到药物治疗

Zhuangzhuang Zhang1, Jianwen Deng1, Weiping Sun1

  • 1Department of Neurology, Peking University First Hospital, Beijing, China.

Brain and behavior
|December 31, 2024
PubMed
概括

大脑洞腔形 (CCM) 源于基因突变,可以用像他类药物这样的药物来治疗. 对CCM机制和治疗方法的进一步研究对于更好的患者结果至关重要.

关键词:
大脑洞腔形形发生生殖线突变的生殖线突变.药物治疗药物治疗身体突变是一种体质突变.

更多相关视频

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.5K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.5K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
89
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
46.2K